Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002317493 | SCV000850892 | uncertain significance | Inborn genetic diseases | 2017-05-24 | criteria provided, single submitter | clinical testing | The p.L1311R variant (also known as c.3932T>G), located in coding exon 20 of the SCN2A gene, results from a T to G substitution at nucleotide position 3932. The leucine at codon 1311 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |